Adaptor-Related Protein Complex 2, alpha 1 Subunit (AP2A1) Peptide
AP2A1
Reactivité: Humain, Souris
Hôte: Synthetic
BP, BI
-
- Antigène Tous les produits alpha Adaptin (AP2A1)
- alpha Adaptin (AP2A1) (Adaptor-Related Protein Complex 2, alpha 1 Subunit (AP2A1))
- Origine
- Humain, Souris
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Attributs du produit
- AP2A1 peptide corresponds to 22 amino acids of AP2A1.
-
-
- Indications d'application
- AP2A1 peptide is used for blocking the activity of AP2A1 antibody . The AP2A1 antibody ships at 0.5 mg/mL and the STK36 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide..
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- AP2A1 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
- Antigène
- alpha Adaptin (AP2A1) (Adaptor-Related Protein Complex 2, alpha 1 Subunit (AP2A1))
- Synonymes
- ADTAA Peptide, AP2-ALPHA Peptide, CLAPA1 Peptide, adtaa Peptide, clapa1 Peptide, ap2-alpha Peptide, AP2A1 Peptide, Adtaa Peptide, adaptor related protein complex 2 alpha 1 subunit Peptide, adaptor-related protein complex 2, alpha 1 subunit Peptide, AP-2 complex subunit alpha-1 Peptide, AP2A1 Peptide, ap2a1 Peptide, Ap2a1 Peptide, EDI_093420 Peptide, EDI_259990 Peptide
- ID gène
- 160
- NCBI Accession
- NP_055018
- OMIM
- 19913414
- UniProt
- O95782
-
Vous êtes ici:
